SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,490.00    40.00 (0.90%)
Bid:
4,400.00
Ask:
4,580.00
Spread: 180.00 (4.091%)
Market Cap: £299.07m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Statement

18 Jul 2012 07:00

RNS Number : 8953H
Judges Scientific PLC
18 July 2012
 

 

 

Judges Scientific plc

Trading Statement

18 July 2012

Judges Scientific plc ('Judges Scientific', the 'Company' or the 'Group')

Trading Update

The Directors of Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, are pleased to update shareholders and the market with regard to the Group's trading performance during the first half of the current financial year.

The Group recorded a solid trading performance during the period to 30 June 2012. The interim results, scheduled to be announced in September, are expected to show organic revenue growth of almost 8% compared with the six months to 30 June 2011. This advance in revenue increases to 39% when account is taken of businesses purchased since 1 January 2011, including a full six months of turnover from Deben and a first time contribution from Global Digital Systems ("GDS") and KE Developments ("KED"). The Board anticipates that interim profits and earnings per share before exceptional items will reflect this satisfactory performance.

GDS and KED were acquired on 6 March 2012 and both have since traded in line with management's expectations. The KED business was successfully relocated into Deben's Woolpit premises during the course of June 2012.

Order intake during the six-month period showed organic growth of 14%. The order book at 30 June 2012 represented ten weeks of sales, somewhat ahead of the level at the beginning of the year, partly as a result of the strong order intake and partly due to the fact that GDS's order book tends to be longer than the Group average.

The balance sheet will show a comfortable cash surplus as at 30 June 2012. Net debt had been eliminated altogether by the end of February, before £8.0 million was borrowed in March to finance the acquisition of GDS. However, the share placing in May raised £2.8 million (net) and this can be assumed to have reduced the level of gearing to less than one-times pro-forma historic EBITA.

The Board continues to be mindful that the global economic climate is fraught with uncertainty. Public spending restraint in Europe, the strength of Sterling, the embattled status of the Euro and fears of deceleration in China are all factors which are capable of affecting our businesses. There can be no complacency and the Board views the current trading environment with balanced measures of vigilance and confidence.

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

Pascal Keane, Edwards Mansfield, Shore Capital: Tel: 020 7408 4090

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGMNRNRGZZM
Date   Source Headline
16th Apr 20257:00 amRNSBoard Change and formation of Executive Committee
8th Apr 202512:35 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSDirector/PDMR Shareholding
3rd Apr 20257:00 amRNSConfirmation of Full Year Results
19th Mar 20257:00 amRNSUnaudited Preliminary Results
6th Mar 20254:08 pmRNSDirector/PDMR Shareholding
20th Feb 20257:00 amRNSNotice of Investor Presentation
7th Feb 202510:32 amRNSDirector/PDMR Shareholding
3rd Feb 202511:11 amRNSTotal Voting Rights
24th Jan 20256:23 pmRNSDirector/PDMR Shareholding
24th Jan 20253:24 pmRNSHolding(s) in Company
23rd Jan 20257:00 amRNSGrant of Options
20th Jan 20257:00 amRNSFull Year Trading Statement and Notice of Results
9th Jan 202511:44 amRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20249:39 amRNSBlocklisting Return
20th Dec 20247:00 amRNSBoard Change
6th Dec 20241:07 pmRNSDirector/PDMR Shareholding
4th Dec 20246:09 pmRNSDirector/PDMR Shareholding
18th Nov 20247:00 amRNSTrading Update
12th Nov 20245:09 pmRNSDirector/PDMR Shareholding
6th Nov 20245:03 pmRNSDirector/PDMR Shareholding
31st Oct 20244:12 pmRNSTotal Voting Rights
18th Oct 20242:20 pmRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
7th Oct 20244:42 pmRNSDirector/PDMR Shareholding
2nd Oct 20249:53 amRNSDirector/PDMR Shareholding
26th Sep 20241:22 pmRNSHolding(s) in Company
26th Sep 202412:31 pmRNSDirector/PDMR Shareholding
25th Sep 20244:59 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSInterim Results
6th Sep 20244:26 pmRNSDirector/PDMR Shareholding
2nd Sep 20247:00 amRNSExecutive Director and Board Appointment
29th Aug 20247:00 amRNSGeotek coring contract
21st Aug 20247:00 amRNSNotice of Investor Presentation
15th Aug 20247:00 amRNSAcquisition of Magsputter Limited
8th Aug 20249:21 amRNSDirector/PDMR Shareholding
30th Jul 20242:45 pmRNSDirector/PDMR Shareholding
29th Jul 20244:53 pmRNSDirector/PDMR Shareholding
25th Jul 20247:00 amRNSHalf Year Trading Update and Notice of Results
8th Jul 20244:54 pmRNSDirector/PDMR Shareholding
3rd Jul 20247:00 amRNSAmendment and Extension of Bank Facilities
28th Jun 20247:00 amRNSAcquisition of Rockwash Geodata Ltd
21st Jun 20244:06 pmRNSBlocklisting Return
7th Jun 20244:42 pmRNSDirector/PDMR Shareholding
6th Jun 20245:18 pmRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSTotal Voting Rights
21st May 20245:28 pmRNSResult of AGM and GM
21st May 20247:00 amRNSAGM Statement
10th May 20245:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.